Related references
Note: Only part of the references are listed.Daptomycin Concentrations in Valve Tissue and Vegetation in Patients with Bacterial Endocarditis
Carlo Tascini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy
F. Kate Gould et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Clinical Experience With Daptomycin for Outpatient Parenteral Antibiotic Therapy
Julius Larioza et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
Breakthrough Bacteremia and Septic Shock Due to Streptococcus anginosus Resistant to Daptomycin in a Patient Receiving Daptomycin Therapy
Federico Palacio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Genetic Basis for Daptomycin Resistance in Enterococci
Kelli L. Palmer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci
Carlos Cervera et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
Cesar A. Arias et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus
J. M. Miro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century
David R. Murdoch et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Infective Endocarditis (Guidelines on Prevention, Diagnosis and Treatment)
Gilbert Habib et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin
Dilip Nathwani
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Gilbert Habib et al.
EUROPEAN HEART JOURNAL (2009)
Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus
Francesc Marco et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)
Elena Loza et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2008)
Frequency of Occurrence and Daptomycin Susceptibility Rates of Gram-positive Organisms Causing Bloodstream Infections in Cancer Patients
H. S. Sader et al.
JOURNAL OF CHEMOTHERAPY (2008)
Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus
Jose M. Miro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Infective endocarditis due to penicillin-resistant viridans group streptococci
Bettina Knoll et al.
CLINICAL INFECTIOUS DISEASES (2007)
Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)
Michael A. Pfaller et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Infective endocarditis - Diagnosis, antimicrobial therapy, and management of complications - A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association
LM Baddour et al.
CIRCULATION (2005)
Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis
JM Streit et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics
E Presterl et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease
K Westling et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora
H Seppälä et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Share Paper
